Conmed (CNMD) Misses Q1 EPS by 2c, Offers FY15 Guidance
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $46.93 --0%
EPS Growth %: -7.4%
Financial Fact:
Weighted average common shares Basic: 27.82M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -7.4%
Financial Fact:
Weighted average common shares Basic: 27.82M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q1 EPS of $0.42, $0.02 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $177.9 million versus the consensus estimate of $176.16 million.
Conmed sees FY2015 EPS of $1.82-$1.92, versus the consensus of $1.86. Conmed sees FY2015 revenue of $723-738 million, versus the consensus of $732.62 million.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Shoe Station Group Inc. (SHOE) Tops Q2 EPS by 11c ; Offers Guidance
- Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance
- Navan, Inc. (NAVN) Tops Q2 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
